Underestimating COVID-19
The COVID-19 pandemic is not over, and vaccination of vulnerable groups can be expected to decrease mortality.
In the first year of battle, strategy was one dimensional. The virus is mutating and research needs to get ahead.
Research must use basic pathological examination to understand the differences in mild and severe disease.
Utilize the worldwide network of scientists to map physiology, histology and biochemical changes within 72 hours of infection (not symptoms) to understand the strategy of the virus.
A second chance is here.